Navigation Links
Leading Neurosurgical Center in Moscow Purchases CyberKnife System to Expand Ability to Treat Brain and Spinal Tumors
Date:8/7/2008

The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release relating to clinical studies, regulatory review and approval, and commercialization of products are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: market acceptance of products; competing products, the combination of our products with complementary technology; and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for the year ended June 30, 2007 as updated from time to time by our quarterly reports on Form 10-Q and our other filings with the Securities and Exchange Commission. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.


'/>"/>
SOURCE Accuray Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. Leading-edge body sensor could help produce sporting champions
5. Hospital Quality Info on Web Can Be Misleading
6. AT&T Establishes New Network Services for Leading Medical Liability Insurer
7. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
10. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
11. Long Term Care Insurance Gains Momentum Thanks to State Promotions, a Leading Brokerage Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... the Lupus Foundation of America and the Saint Thomas, ... -- Julian Lennon, son of the legendary John Lennon, ... single, "LUCY," to raise funds for research on the ... percent of the proceeds from downloading "LUCY" at iTunes ... (LFA), and the Saint Thomas, Lupus Trust in Great ...
(Date:12/15/2009)... Incidence fell in area where all couples of reproductive ... 14 (HealthDay News) -- The number of children born ... who might be CF mutation carriers increases, a new ... in an area of northeast Italy for many years. ... progressive decline in the number of infants born with ...
(Date:12/15/2009)... have lower strength than needed for protection, CDC says, ... children,s doses of H1N1 swine flu vaccine have been ... lost some potency, federal health officials said Tuesday. , ... Prevention, the company,s routine testing of the vaccine for ... that four batches had lower than required potency levels. ...
(Date:12/15/2009)... Interactive education program will train advocates to be ... Project developed with support from experts in ... ,, WASHINGTON, Dec. 15 ... they are accepting applications for the first-ever "Malaria ... train and educate participants to become leaders in ...
(Date:12/15/2009)... PLAINS, N.Y., Dec. 15 Team In ... groundbreaking charity sports training program, has ... to support blood cancer research and patient services. ... been the pre-eminent charity endurance sports training program, ... marathon, half marathon, triathlon, 100-mile century cycle ride ...
Breaking Medicine News(10 mins):Health News:Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research 2Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2Health News:Large Recall of Children's Swine Flu Vaccine 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4Health News:$1 Billion - For Charity! 2Health News:$1 Billion - For Charity! 3
... half of those in ICU had deficient levels, study shows ... are deficient in many critically ill patients, new research shows. ... half of people in an intensive care unit were deficient ... be common in seriously ill patients," said study author Dr. ...
... April 29 Varian Medical Systems (NYSE: ... of $0.64 per diluted share in the second quarter ... operations of $0.57 per diluted share in the year-ago ... net earnings per diluted share in the quarter were ...
... SGMO ) today reported first quarter 2009 financial ... 2009, Sangamo reported a consolidated net loss of $6.8 million, ... $8.0 million, or $0.20 per share, for the same period ... cash and cash equivalents, marketable securities and interest receivable of ...
... improves quality of sleep for patients, study finds, , , ... used to treat epilepsy, nerve pain, anxiety and fibromyalgia, ... syndrome, a Spanish researcher reports. , Some 5 percent ... have restless legs syndrome (RLS), a disorder that causes ...
... to the American Red Cross and receive a scratch ticket ... for a yearDEDHAM, Mass., April 29 During the month ... drives in Massachusetts, New Hampshire and Connecticut, along with select ... to "Scratch & Win with Uno Chicago Grill(R)." The Boston-based ...
... 29 Speaker Nancy Pelosi spoke ... final House-Senate budget resolution for fiscal year 2010. The resolution passed ... expected to be approved by the Senate later today. It does ... remarks: "Madam Speaker, it is indeed an honor ...
Other Medicine News:Health News:Critically Ill Patients Lack Vitamin D 2Health News:Critically Ill Patients Lack Vitamin D 3Health News:Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009 2Health News:Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009 3Health News:Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009 4Health News:Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009 5Health News:Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009 6Health News:Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009 7Health News:Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009 8Health News:Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009 9Health News:Sangamo BioSciences Reports First Quarter 2009 Financial Results 2Health News:Sangamo BioSciences Reports First Quarter 2009 Financial Results 3Health News:Sangamo BioSciences Reports First Quarter 2009 Financial Results 4Health News:Sangamo BioSciences Reports First Quarter 2009 Financial Results 5Health News:Sangamo BioSciences Reports First Quarter 2009 Financial Results 6Health News:Sangamo BioSciences Reports First Quarter 2009 Financial Results 7Health News:Common Drug Eases Restless Legs Syndrome 2Health News:Try Your Luck with 'Scratch & Win with Uno Chicago Grill'! 2Health News:Try Your Luck with 'Scratch & Win with Uno Chicago Grill'! 3Health News:Pelosi: Budget is a Blueprint for the Future 2Health News:Pelosi: Budget is a Blueprint for the Future 3Health News:Pelosi: Budget is a Blueprint for the Future 4
(Date:12/16/2009)... Belgium, December 16 , ... Program With Microplasmin Recruits a Total of ... ThromboGenics NV (Euronext Brussels: ... and development of innovative treatments for eye,disease, ... it has completed,the enrolment of the second ...
(Date:12/15/2009)... Dec. 15 Warner Chilcott plc (Nasdaq: ... Warner Chilcott Corporation (the "Company") has commenced a ... to the conditions set forth in the Company,s ... December 15, 2009 (the "Offer to Purchase"), for ... subordinated notes due 2015 (the "Notes"). ,, The ...
(Date:12/15/2009)... Cellular Dynamics International ... iCell(TM) Cardiomyocytes for use in testing of new ... human heart cells are designed to aid drug ... efficacy and toxicity screens, weeding out ineffective and ... process before significant time and resources have been ...
Breaking Medicine Technology:ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 2Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 3Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 4Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 5Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 6Cellular Dynamics Announces Commercial Launch of iCell(TM) Cardiomyocytes for Drug Candidate Toxicity Screening 2Cellular Dynamics Announces Commercial Launch of iCell(TM) Cardiomyocytes for Drug Candidate Toxicity Screening 3Cellular Dynamics Announces Commercial Launch of iCell(TM) Cardiomyocytes for Drug Candidate Toxicity Screening 4Genova files patent for new prostate cancer treatment 56395 1Genova files patent for new prostate cancer treatment 56395 2Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 1Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 2Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 3Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 4Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 5Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 6Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 7Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 8Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 9Reportlinker Adds Small Molecule Kinase Inhibitors Report 13902 10Organic weed control for dandelions 9824 1Organic weed control for dandelions 9824 2
... June 13 , NicOx S.A. (Euronext Paris: ... pressure data from the 301 phase 3 study, ... in,terms of the mean change from baseline in ... for 3 out of 4 comparisons). Commonly used,Non-Steroidal ...
... June 12 XTENT, Inc.,(Nasdaq: XTNT ) ... the designated European Notified Body for CE Mark ... Notified Body confirmed that recently,presented six-month follow up ... by the Drug Agency, which reviews the drug ...
Other Medicine Technology:NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR 2NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR 3NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR 4XTENT Announces European Regulatory Update 2XTENT Announces European Regulatory Update 3
... laser is mounted on Haag Streit slit-lamp. ... 0.2 and 2.0 mJ. The spot size ... microns. Knobs for laser energy and aiming ... laser head. The laser system complies with ...
... laser system provides two lasers in the ... photodisruptor for posterior capsulotomy and iridotomy. The ... pulsed 532 nm light. The photodisruptor laser ... appropriate laser can be easily selected and ...
... The Selecta II Glaucoma Laser System features ... patients with open-angle glaucoma. It selectively targets ... intraocular pressure. The Selecta II is equipped ... high-energy beam of light, which induces the ...
Thin and smooth jaws, designed to enter trough 3 mm incision, cross action....
Medicine Products: